White Brook Insights | Basil Alsikafi | Substack

Sanara Medtech ($SMTI) 2-3x

Please find enclosed White Brook Capital’s thesis on Sanara Medtech, ticker SMTI.

Dec 4, 2025 • Basil Alsikafi

Information. Asymmetry. Profit.

Economically, the tide, if not going out, is much less strong than it once was.

Nov 26, 2025 • Basil Alsikafi

$RPID Thesis Update into the 2H Reports

Rapid Bio Microsystems is the largest position in the Small and Micro-cap strategy and is also a holding in the All-Cap strategy.

Oct 29, 2025 • Basil Alsikafi

White Brook Capital 3Q25 Quarterly Commentary

Today, White Brook released its 3rd quarter 2025 commentary.

Oct 16, 2025 • Basil Alsikafi

Career Advice for Aspiring Investment Management Analysts and Interns

With the beginning of the school year approaching, the email flow from eager students “asking for advice/a job” is about to escalate.

Aug 4, 2025 • Basil Alsikafi

White Brook Insights

About Archive Recommendations Sitemap

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts